STAT Plus: Novo Nordisk becomes latest insulin maker seeking to foster goodwill amid Covid-19
Yet another large insulin maker is trying to soften the financial hit many people are feeling due to the pandemic with a program that lowers costs for people with diabetes.
This time around, Novo Nordisk (NVO) is offering insulin free of charge for 90 days to those who can prove they lost their private health care insurance due to job loss, and the offer will be extended through the end of the year for anyone who is denied Medicaid benefits.
Continue to STAT Plus to read the full story…
